Literature DB >> 15021325

Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography.

Martin Krix1, Fabian Kiessling, Marco Essig, Felix Herth, Andreas Karcher, Martin Le-Huu, Hans-Ulrich Kauczor, Stefan Delorme.   

Abstract

RATIONALE AND
OBJECTIVES: We investigated whether observing the arterial vascularization of liver metastases by contrast-enhanced ultrasound with low mechanical index (low-MI) imaging offers additional diagnostic information for the characterization of the liver lesions.
METHODS: Twenty nine patients with untreated liver metastases of different primaries were examined. Measurements were performed using a low frame rate, low-MI pulse inversion technique after injection of 2.4 mL SonoVue. The relative maximum signal intensity of the liver lesions related to the normal liver tissue was quantified. Ultrasound findings were compared with contrast-enhanced, dual-phase computed tomography (CT) using a pattern-based classification scheme.
RESULTS: Compared with contrast-enhanced CT, this modality better detects arterial perfusion. Metastases, even those usually considered hypovascularized, often showed homogeneous enhancement (66%) and higher arterial vascularization than normal liver tissue. CT did not show a comparable vascularization pattern (P < 0.001) or any similarly early signal intensity (P < 0.001).
CONCLUSIONS: Contrast-enhanced CT may not be able to visualize short-lasting but large differences of the arterial perfusion of liver metastases, as does contrast-enhanced low-MI ultrasound. This offers new methods for their characterization and for monitoring of therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021325     DOI: 10.1097/01.rli.0000116361.62063.b5

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

1.  Computer-aided diagnosis for contrast-enhanced ultrasound in the liver.

Authors:  Katsutoshi Sugimoto; Junji Shiraishi; Fuminori Moriyasu; Kunio Doi
Journal:  World J Radiol       Date:  2010-06-28

Review 2.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

3.  Standardize and compare contrast-enhanced ultrasonographic digital images obtained with different technologies: how to overcome the subjectivity.

Authors:  Mirko D'Onofrio; Niccolò Faccioli; Roberto Malagò; Giulia Zamboni; Roberto Pozzi Mucelli
Journal:  J Digit Imaging       Date:  2007-09       Impact factor: 4.056

4.  Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis.

Authors:  Yang Guang; LiMei Xie; Hailong Ding; AiLu Cai; Ying Huang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-18       Impact factor: 4.553

5.  Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.

Authors:  M Krix; C Plathow; M Essig; K Herfarth; J Debus; H-U Kauczor; S Delorme
Journal:  Eur Radiol       Date:  2005-02-24       Impact factor: 5.315

6.  [Contrast-enhanced sonography of the liver].

Authors:  M M Uggowitzer; G Gotschuli; H Reiter; B Petek
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

7.  Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation.

Authors:  Hong Wu; Qiang Lu; Yan Luo; Xian-Lu He; Yong Zeng
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

8.  Non-invasive imaging for studying anti-angiogenic therapy effects.

Authors:  Josef Ehling; Twan Lammers; Fabian Kiessling
Journal:  Thromb Haemost       Date:  2013-02-14       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.